CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Welcome to Capital.com. The products and services listed on this website are not available to US residents.

Trade BioCryst - BCRX CFD

7.55
2.58%
0.07
Low: 7.31
High: 7.55
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon: 14:30 - 21:00

Tue: 14:30 - 18:00

Thu - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023374 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023374%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001151 %
Charges from full value of position ($0.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001151%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 7.36
Open 7.33
1-Year Change 21.76%
Day's Range 7.31 - 7.55
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 19, 2024 7.36 0.05 0.68% 7.31 7.44 7.18
Dec 18, 2024 7.28 -0.11 -1.49% 7.39 7.56 7.12
Dec 17, 2024 7.45 0.24 3.33% 7.21 7.58 7.20
Dec 16, 2024 7.42 0.03 0.41% 7.39 7.50 7.17
Dec 13, 2024 7.51 0.01 0.13% 7.50 7.59 7.40
Dec 12, 2024 7.57 -0.16 -2.07% 7.73 7.87 7.55
Dec 11, 2024 7.83 -0.02 -0.25% 7.85 8.04 7.79
Dec 10, 2024 7.90 0.27 3.54% 7.63 7.96 7.63
Dec 9, 2024 7.70 0.11 1.45% 7.59 7.77 7.53
Dec 6, 2024 7.57 -0.26 -3.32% 7.83 8.12 7.57
Dec 5, 2024 7.82 0.52 7.12% 7.30 7.88 7.30
Dec 4, 2024 7.28 0.13 1.82% 7.15 7.52 7.09
Dec 3, 2024 7.16 -0.14 -1.92% 7.30 7.39 7.11
Dec 2, 2024 7.34 -0.09 -1.21% 7.43 7.45 7.18
Nov 29, 2024 7.46 0.03 0.40% 7.43 7.48 7.33
Nov 27, 2024 7.47 -0.02 -0.27% 7.49 7.58 7.39
Nov 26, 2024 7.46 0.27 3.76% 7.19 7.50 7.13
Nov 25, 2024 7.23 -0.27 -3.60% 7.50 7.63 7.21
Nov 22, 2024 7.58 0.14 1.88% 7.44 7.62 7.38
Nov 21, 2024 7.45 0.27 3.76% 7.18 7.47 6.98

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

680K+

Traders

101K+

Active clients monthly

$215B+

Monthly trading volume

$46M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

BioCryst Company profile

BioCryst (BCRX) is a commercial-stage biotech firm that discovers novel, oral, small-molecule medicines. 

The company focuses on oral treatments for rare diseases in which significant unmet medical needs exist. BioCryst’s drug portfolio consists of ORLADEYO for prevention of hereditary angioedema. ORLADEYO has been approved in the US, EU, UK, Japan and UAE. Other drugs like RAPIACTA, RAPIVAB and PERAMIFLU are approved in select geographies. 

The company is developing an oral small molecule Factor D inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria and other complement-mediated diseases.

According to the company, its focus on rare diseases market helps it control costs effectively. BioCryst selects disease targets and product candidates in which a small molecule would offer a significant benefit over existing products or would be the first to market.

BioCryst’s US headquarters is located in Durham, North Carolina while its European headquarters is in Dublin, Ireland. Jon P Stonehouse is the chief executive officer and William P Sheridan is the chief medical officer of BioCryst.

The company was founded in 1966. It completed its initial public offering (IPO) in March 1994 and is listed on the Nasdaq stock exchange under the ticker symbol BCRX. According to the company’s price history, BCRX stock price hit an all-time high of $37.25 on 1 March 2000. 

You can follow the ups and downs of the BioCryst stock price at Capital.com. Always stay on top of the latest price developments with our live BCRX stock chart.

Industry: Bio Therapeutic Drugs

4505 Emperor Blvd Ste 200
DURHAM
NORTH CAROLINA 27703-8457
US

People also watch

ETH/USD

3,475.35 Price
+1.490% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

XRP/USD

2.29 Price
+1.170% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01143

BTC/USD

97,582.85 Price
+0.240% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

US100

21,269.40 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading